ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION

Ducommun Incorporated

NYSE:DCO 株式レポート

時価総額:US$2.5b

  • 会社概要
  • 評価
  • 将来の成長
  • 過去の実績
  • 財務の健全性
  • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

Ducommun 配当と自社株買い

配当金 基準チェック /06

Ducommun配当金を支払った記録がありません。

主要情報

n/a

配当利回り

0.1%

バイバック利回り

総株主利回り0.1%
将来の配当利回り0%
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当と自社株買いの更新

更新なし

Recent updates

User avatar
ナラティブ更新 • Sep 05

DCO: Missiles Demand Will Drive Future Repricing Despite Legacy Defense Concerns

Analysts have raised their Ducommun price target from $150 to $200, citing updated aerospace and defense models, stronger profit margin assumptions, recent growth in the missiles business, and support from higher Street targets clustered between $175 and $228. Analyst Commentary on Ducommun Recent research on Ducommun reflects a mix of optimism about the missiles business and caution about how much of that story is already reflected in the current share price.
User avatar
ナラティブ更新 • Aug 22

DCO: Missile Upside And Aero Recovery Will Offset Valuation And Budget Headwinds

The analyst fair value estimate for Ducommun has been raised from $190.80 to $212.00 as analysts factor in higher Street price targets from Citi and Truist, supported by reported missiles growth and updated aerospace and defense models. Analyst Commentary Recent Street commentary on Ducommun gives you a mix of optimism around missiles exposure and commercial aerospace, with some caution on how much of that story is already reflected in the share price.
User avatar
新しいナラティブ • Aug 09

Missile Backlog And Engineered Products Will Reshape This Aerospace Supplier’s Long-Term Prospects

Catalysts About Ducommun Ducommun supplies engineered products and complex electronic and structural solutions to Commercial Aerospace, Military and Space customers. What are the underlying business or industry changes driving this perspective?
User avatar
ナラティブ更新 • Aug 07

DCO: Missile Upside And Aero Recovery Will Balance Defense Budget Pressure

Ducommun's analyst fair value estimate has been updated from $181 to $190.80 as analysts factor in higher profit margin assumptions, a slightly lower future P/E multiple, and ongoing discussion around missile and munitions exposure versus potential budget pressure on legacy defense programs. Analyst Commentary Recent Street research on Ducommun gives you a mixed picture that focuses on execution in missiles and munitions, exposure to commercial aerospace, and how much of this is already captured in the valuation.
User avatar
ナラティブ更新 • Jul 23

DCO: Missile Demand And Aero Recovery Will Offset Defense Budget Concerns

Analysts have lifted their fair value estimate for Ducommun stock from $173.80 to $181.00, reflecting updated views that incorporate recent price target increases across the Street, along with expectations for continued benefits from commercial aerospace strength and missile and munitions demand, tempered by potential budget pressure on parts of the legacy defense portfolio. Analyst Commentary Recent research on Ducommun points to a split view, with bullish analysts highlighting earnings execution and exposure to commercial aerospace and missiles, while more cautious analysts focus on valuation and defense budget risk.
Seeking Alpha • Jul 14

Ducommun Incorporated: Real Defense Tailwinds, Few Good Reasons To Wait

Summary Ducommun Incorporated is shifting revenue toward defense, now comprising 58% of FY25 revenues, driving recent stock rerating. I rate DCO a Hold, citing limited current upside, ongoing litigation overhang, and a need for a more defense-centric revenue mix. Valuation remains below peers like Hexcel, but further upside depends on a stronger defense shift and litigation resolution. Existing holders may continue to hold, but new buyers should wait for a better entry price and clearer catalysts. Read the full article on Seeking Alpha
User avatar
ナラティブ更新 • Jul 09

DCO: Missile Demand And Aero Recovery Will Balance Defense Budget And Execution Risks

For Ducommun, the analyst fair value estimate has been revised to $173.80 from $164.00. Analysts point to updated price targets, expectations around missiles and munitions demand, and recent earnings and sector research as the key drivers of this change.
User avatar
新しいナラティブ • Jul 02

Missile Demand And Engineered Content Shifts Will Expose Overvaluation Risks

Catalysts About Ducommun Ducommun supplies engineered components and assemblies for commercial aerospace, defense and related industrial applications. What are the underlying business or industry changes driving this perspective?
User avatar
ナラティブ更新 • Jun 25

DCO: Q1 Execution And Aero Recovery Will Balance Restatement Governance Risks

Analysts have lifted their blended price target on Ducommun to approximately $164, reflecting updated models following the company’s Q1 earnings beat and improving commercial aerospace trends, alongside ongoing destocking concerns. Analyst Commentary on Ducommun Recent research on Ducommun points to a generally constructive tone, with price targets raised across multiple firms following the Q1 report and sector model updates, while still flagging a few key risks around end market trends and inventory normalization.
User avatar
ナラティブ更新 • Jun 11

DCO: Q1 Execution And Defense Outlook Will Offset Restatement Governance Risks

Narrative Update on Ducommun Analysts have collectively raised their price targets on Ducommun into a range of about $150 to $187, citing Q1 earnings outperformance, better than expected commercial aerospace demand despite ongoing destocking, and updated aerospace and defense sector models that still indicate potential upside following recent selloffs. Analyst Commentary Recent research updates reflect a generally constructive stance on Ducommun, with higher price targets supported by Q1 execution and expectations around aerospace and defense demand, while still flagging some execution and end market risks.
User avatar
ナラティブ更新 • May 28

DCO: Vision 2032 And Defense Backlog Will Offset Aerospace Destocking Risks

Analysts have lifted the Ducommun fair value estimate from $146.60 to $164.00, reflecting higher sector price targets after Q1 earnings beats and updated assumptions around revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Ducommun highlights a broadly constructive tone after the latest Q1 earnings and earlier Q4 results, with several firms revisiting their models and price targets.
User avatar
ナラティブ更新 • Apr 29

DCO: Defense Backlog And Vision 2032 Framework Will Steady Fair Outlook

Ducommun's updated fair value estimate has moved from $143.20 to $146.60 as analysts factor in a series of higher price targets tied to defense exposure, missile program visibility, and recent margin and backlog trends. Analyst Commentary Recent Street research on Ducommun centers on defense exposure, missile program visibility, and margin execution, which together are feeding into higher fair value estimates and revised price targets.
User avatar
ナラティブ更新 • Apr 10

DCO: Defense Exposure And Vision 2032 Plan Will Shape Balanced Outlook

Analysts have made a slight trim to the Ducommun price target, lowering it by about $0.40. They are balancing recent target hikes tied to defense exposure, missile demand and margin plans with a modest reset following the latest Citi update.
User avatar
ナラティブ更新 • Mar 27

DCO: Defense Exposure And Vision 2032 Plan Will Drive Long Term Upside

Analysts have nudged the Ducommun fair value estimate higher from $142.00 to $143.60. This reflects recent price target increases that are tied to expectations around defense exposure, missile related demand and updated margin ambitions discussed in recent research.
User avatar
ナラティブ更新 • Mar 12

DCO: Defense Momentum And Vision 2032 Plan Will Shape Upside Through 2026

Narrative Update on Ducommun The analyst price target embedded in our fair value framework for Ducommun has been raised from $130 to $142. This change reflects analysts' higher published targets in the $136 to $155 range, supported by recent commentary around margin expansion, record Q4 revenue and EBITDA, defense program visibility, and the Vision 2032 plan focused on proprietary products and free cash flow.
User avatar
ナラティブ更新 • Feb 26

DCO: Defense Agreements And Sector Momentum Will Shape Risk Balance Through 2026

The fair value estimate for Ducommun has been raised from $121.60 to $130.00 as analysts factor in higher Street price targets and improved visibility tied to long term defense agreements and updated aerospace and defense group estimates. Analyst Commentary Recent Street research on Ducommun focuses on higher price targets and updated expectations tied to the defense portfolio and broader aerospace and defense coverage.
User avatar
ナラティブ更新 • Feb 11

DCO: Sector Momentum And Refined Assumptions Will Shape Risk Balance Through 2026

Narrative update on Ducommun The analyst price target for Ducommun has been lifted by $3.80 to $121.60. Analysts point to recent sector wide target increases from firms covering aerospace and defense as support for the higher fair value, as well as a slightly adjusted discount rate and future P/E assumptions.
User avatar
ナラティブ更新 • Jan 28

DCO: Sector Momentum And M&A Plans Will Shape Risk Balance Through 2026

Analysts have increased their Ducommun fair value estimate from US$111.40 to US$117.80. This reflects updated assumptions on the discount rate, revenue growth, profit margins, and a higher future P/E multiple in the context of recent sector-wide price target increases.
User avatar
ナラティブ更新 • Jan 13

DCO: Sector Momentum And Accounting Concerns Will Shape Risk Balance Through 2026

Analysts have lifted their price target on Ducommun to about US$111 from roughly US$106, reflecting updated assumptions on revenue growth, profit margins and a lower expected future P/E, alongside recent sector research indicating momentum in aerospace and defense through the first half of 2026. Analyst Commentary Bullish Takeaways Bullish analysts see the higher US$125 price target as reflecting confidence that Ducommun can support a richer valuation while still using a lower future P/E, given their updated revenue and margin assumptions.
User avatar
ナラティブ更新 • Aug 08

Defense Modernization And Aerospace Recovery Will Reshape Markets

Ducommun's upward price target revision reflects notable improvements in both net profit margin and revenue growth forecasts, resulting in an increased consensus fair value from $99.25 to $106.25. What's in the News Ducommun dropped from the Russell 2000 Dynamic Index.
Seeking Alpha • Apr 22

Duocommun: A Good Candidate For A Multi-Year Compounder

Summary Ducommun (DCO) is a promising investment in the aerospace and defense sector, with strong revenue growth potential despite economic challenges. The company’s diverse product offerings and strong financial position support organic growth and acquisitions, with significant contributions from military, space, and commercial aerospace. DCO's backlog and notable contracts with major players like RTX, Boeing, and Airbus indicate robust future revenue and earnings growth. The recent share price drop presents a compelling entry point, with a near-term price target of $75.50 and long-term growth potential. Read the full article on Seeking Alpha
Seeking Alpha • Nov 22

Ducommun: Revenue Growth, Airbus Strength, And Vision 2027 Progress

Summary Ducommun reported 2.6% revenue growth, driven by military, space, and Airbus programs. Margins improved, with adjusted EBITDA margin expanding to 15.8% and adjusted EPS up 41%. Robust performance in Airbus A220 and A320 programs offset challenges from Boeing’s strike. Boeing’s recovery is expected to support growth in 2025-2026, especially for the 737 MAX and 787. Facility consolidations and operational streamlining are delivering initial savings, with projected annual savings of $11-13M. Defense backlog increased to $592M, driven by demand for TOW missiles and surveillance. Margin improvements align with DCO’s Vision 2027 goal of 18% adjusted EBITDA margin, supported by strong end markets, cost reductions, and improving aerospace production outlook. Read the full article on Seeking Alpha
Seeking Alpha • Sep 19

Ducommun: Aerospace Growth And Strategic Restructuring Amid Boeing Challenges

Summary Ducommun continues to report revenue growth for 2Q24, driven by both commercial aerospace and military end markets. Additionally, margins expanded, driven by engineered products, pricing actions, and restructuring efforts. Despite ongoing challenges with Boeing and Spirit AeroSystems related to the 737 MAX, it achieved 12 consecutive quarters of revenue growth in commercial aerospace. Additionally, DCO's fuselage skin project for the 737 MAX, expected to start production by late 2024, is expected to bolster the company's aerospace business outlook. While the Boeing strike presents near-term headwinds, DCO's strategic restructuring and cost-saving initiatives, combined with improving production rates, are expected to boost margins and profitability in the long term. Read the full article on Seeking Alpha
User avatar
新しいナラティブ • Sep 16

Strategic Moves And Aerospace Focus Set To Skyrocket Efficiency And Earnings

Consolidating facilities and increasing engineered products and aftermarket content are key strategies to boost operational efficiency and net margins.
Seeking Alpha • Jul 16

Ducommun: Robust Air Travel Demand And Defence Backlog

Summary DCO's historical financial results have shown consistent top-line growth. However, margins were contracting modestly. For 1Q24, net revenue continued to grow. Additionally, its margins expanded when compared to previous period. DCO's defence backlog is growing, which is a sign that its defence business is growing. Additionally, DCO raised the run rate of the SPY-6 and other defence programmes. Currently, air travel demand is strong, and ICAO forecasts it to continue growing. The robust air travel demand is expected to bolster the DCO outlook. Read the full article on Seeking Alpha
Seeking Alpha • Apr 21

Ducommun: Management Expects Margin Expansion And Revenue Growth

Summary Although Ducommun's commercial aerospace business faced substantial headwinds given the beginning of the pandemic, demand from the market has continued to recover in recent years. On April 16, 2024, Ducommun's board rejected an unsolicited, non-binding indication of interest from Albion River LLC offering $60 in cash per share. Ducommun's board feels the offer doesn't fully reflect the company's Vision 2027 plan where the company sees meaningful adjusted EBITDA margin expansion and continued revenue growth. I rate Ducommun a 'Buy' and I would own it in a diversified portfolio given the company's growth potential and relatively attractive valuation with forward EV/EBITDA ratio of 9.18. Read the full article on Seeking Alpha
分析記事 • Apr 17

We Think Shareholders May Want To Consider A Review Of Ducommun Incorporated's (NYSE:DCO) CEO Compensation Package

Key Insights Ducommun to hold its Annual General Meeting on 24th of April Salary of US$959.7k is part of CEO Steve...
分析記事 • Feb 18

Ducommun Incorporated Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shareholders might have noticed that Ducommun Incorporated ( NYSE:DCO ) filed its annual result this time last week...
Seeking Alpha • Feb 06

Ducommun Stock Is Still A Buy On End Market Growth

Summary Ducommun Incorporated has gained 12.9% since September 2023, outperforming the S&P 500. The company operates in the aerospace industry, serving major companies such as Boeing and Airbus. Ducommun has significant growth drivers, including exposure to commercial airplane programs and increased defense budgets. Read the full article on Seeking Alpha
Seeking Alpha • Sep 14

Ducommun Aims For A Bigger Piece Of A Growth Pie

Summary Ducommun Incorporated provides engineering and manufacturing services for various industries, including aerospace and defense. Ducommun aims to achieve significant revenue growth and increase its EBITDA through restructuring, cost-cutting measures and accretive acquisitions. The company aims to expand its portfolio and extract more value from that portfolio. Read the full article on Seeking Alpha

決済の安定と成長

配当データの取得

安定した配当: DCOの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: DCOの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

Ducommun 配当利回り対市場
DCO 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (DCO)n/a
市場下位25% (US)1.4%
市場トップ25% (US)4.1%
業界平均 (Aerospace & Defense)1.2%
アナリスト予想 (DCO) (最長3年)0%

注目すべき配当: DCOは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: DCOは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: DCOの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。


株主配当金

キャッシュフローカバレッジ: DCOが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/11 12:36
終値2026/09/11 00:00
収益2026/07/04
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Ducommun Incorporated 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13

アナリスト機関
Michael CrawfordB. Riley Securities, Inc.
Kenneth HerbertCanaccord Genuity
John GodynCitigroup Inc

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド